1. Community-acquired pneumonia caused by Micrococcus antarcticus: a rare case report.
- Author
-
Xu J, Zhang Y, Shi L, Wang H, Zeng M, and Lu Z
- Subjects
- Humans, Female, Aged, 80 and over, Pneumonia, Bacterial microbiology, Pneumonia, Bacterial diagnosis, Pneumonia, Bacterial drug therapy, Bronchoalveolar Lavage Fluid microbiology, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Pneumonia microbiology, Pneumonia diagnosis, Pneumonia drug therapy, Gram-Positive Bacterial Infections microbiology, Gram-Positive Bacterial Infections drug therapy, Gram-Positive Bacterial Infections diagnosis, Community-Acquired Infections microbiology, Community-Acquired Infections drug therapy, Community-Acquired Infections diagnosis, Micrococcus isolation & purification, Micrococcus genetics, Anti-Bacterial Agents therapeutic use, RNA, Ribosomal, 16S genetics
- Abstract
Background: Micrococcus antarcticus (M. antarcticus) is an aerobic Gram-positive spherical actinobacterium that was initially isolated from Chinese Great-Wall station in Antarctica in 2000. M. antarcticus was considered to be of low pathogenicity, no previous cases of human infection by this organism have been reported. Here we describe the first report with community-acquired pneumonia (CAP) caused by M. antarcticus., Case Presentation: An 87-year-old female was presented to the Central Hospital of Wuhan in November 2023 with a chief complaint of cough, sputum production, and chest tightness for 2 weeks. Microbial culture of the patient's bronchoalveolar lavage fluid (BALF) and identification of the isolates using Matrix-assisted laser desorption ionization/time of flight mass spectrometry (MALDI-TOF MS) and 16S rRNA gene sequencing revealed M. antarcticus infection. Combined with clinical symptoms, laboratory and imaging examination, the patient was diagnosed with CAP. Then cefoperazone/sulbactam and levofloxacin was administrated, the patient's condition was improved and she was discharged after a week after admission, no abnormalities were detected during a 5-month follow-up., Conclusions: This case highlights that M. antarcticus, first identified from a patient with CAP, is an extremely rare pathogenic microorganism. Clinicians should be aware of its potential as a pathogen in the diagnosis and treatment of CAP., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF